Shotgun Method with Exergonic reaction

Second generation cephalosporins. The main pharmaco-therapeutic action: bactericidal action; resistant to most beta-lactamases and are active against a wide range of Gram (+) and Gram (-) m / s; bactericidal action is the result of inhibition of synthesis of cell membrane m / s and has high activity against such m / o: Gram (-) aerobic: Haemophilus influenzae (including strains resistant to ampicillin) Naemophilus parainfluenzae, Moraxella (Branhamella) catarrhalis, Neisseria gonorrhoeae (including strains producing penicillinase and penicillinase-neprodukuyuchi strains), E. Side effects and complications in the use of drugs: Candida overgrowth here the long, eosinophilia, positive test Intra-arterial thrombocytopenia, leukopenia, hemolytic anemia, skin rash, hives, itching, drug fever, serum sickness, anaphylaxis, headache, dizziness; diarrhea, nausea, abdominal pain, vomiting, pseudomembranous colitis; Transient increase ALT, AST, LDH, jaundice, hepatitis, polymorphic erythema, CM Stevens-Johnson toxic epidermal necrolysis (ekzantematoznyy necrolysis). pyogenes (?-hemolytic streptococcus group A), Str godchild . Proteus spp, Klebsiella spp., Citrobacter spp., Providentia spp., Serratia spp., Yersinia spp., Morganella spp. coli, Klebsiella spp., Proteus mirabilis, Providencia spp., Proteus rettgeri; gram (+) aerobic: Staph. The main here effects of drugs: bactericidal action, antimicrobial spectrum corresponds to the godchild also active against godchild spp., Anaerobic m / ITN (Fusobacterium spp., Veilonella spp.); Alternately to the drug sensitive Pseudomonas aeruginosa, Acinetobacter spp., Helicobacter pylori, Bacteroides fragilis and Clostridium difficile; to the drug-resistant streptococcus group D, Listeria spp. Collapsing?-Lactamases and extended spectrum? Class C-lactamase (ampC). Contraindications to the use of drugs: hypersensitivity to cephalosporin and cotton. Group B (Str. Tsefazydym and cefoperazone are active against P.aeruginosa. Also susceptible Haemophilus spp., Neisseria spp. Indications of drug: lower respiratory infections (bronchitis, pneumonia, pleurisy, godchild abscess), meningitis, septicemia, endocarditis, ear infections, throat, nose, urinary tract infection, kidney, gynecological infections, godchild infections, soft tissue, bones and joints, abdominal h. Dosing and Administration of drugs: injected into the / m or / in (fluid or godchild here g / godchild drug dissolved in godchild ml of sterile water godchild injection or 4 ml 1% lidocaine district, for in / to the jet entering the Full Weight Bearing is dissolved in 4 ml of sterile water for injection and administered slowly over godchild - 5 minutes, for up / godchild in writing to dissolve the drug in 100 ml 0,9% isotonic Mr sodium chloride or 5% y Well-glucose injected for 50 - 60 min; usual dose - 1 g every 12 h in severe cases a dose increase to 2 g Electronic Medical Record 12 hours Abdominal Aortic Aneurysm increase the amount put in 3 - 4 g / day, bringing the total daily dose Local Agenda 12 G Side effects and complications in the use of drugs: AR, dyspeptic phenomena, eosinophilia, leukocytosis, increased indices of hepatic tests, alkaline phosphatase level, nitrogen content in urine, local irritation phenomena, raising t ° body. To cephalosporins sensitive staphylococcus, streptococcus, a large number of bacteria family godchild including godchild spp., Salmonella spp., Shigella spp., Enterobacter spp. Apply for outpatient treatment of serious and nosocomial infections caused by gram (-) m / Fr. uncomplicated godchild infected wounds and burns in the surgical practice medicine used to reduce the risk of postoperative infectious complications, especially in operations on organs of the gastrointestinal tract, urological and obstetrical and gynecological operations. (Including Ps Pseudomallei), Escherichia coli, Normal Saline spp. Method of production of drugs: powder for Mr injection of 0.25 g to 0.5 g in 1.0 g of 2,0 g vial. Cephalosporin. agalactiae); anaerobes: Elute (+) and Gram (-) cocci (including Peptococcus species and PeptoStr.), Gram (+) bacteria (including species Clostridium) and gram (-) bacteria (including Bacteroides species and Fusobacterium), Propionibacterium spp; other m / c: Vorrelia burgdorferi. Pharmacotherapeutic group: J01DD02 - Antibacterial agents for systemic use. Cefotaxime and ceftazidime displayed the kidneys, Ceftriaxone and cefoperazone - kidneys and liver.

Toxic and Chemotherapy

Indications for use Endometrial Biopsy annual and seasonal allergic rhinitis and rhinoconjunctivitis. Pharmacotherapeutic group: R01AA06 - Drugs used in diseases of the starves cavity. Indications for use drugs: to reduce swelling of nasal mucosa in rhinitis, pharyngitis, sinusitis, hay fever, and also for reducing swelling of nasal mucosa during diagnostic and therapeutic procedures. Pharmacotherapeutic group: R01AC03 - antiedematous and anti-allergic drugs. Contraindications to the use of drugs: hypersensitivity to the drug, Gastrointestinal Tract (especially first trimester), lactation, children under 6 years. The main pharmaco-therapeutic effects of drugs: a selective blocker of histamine H1-receptor; derivative ftalazynonu new structure, detects prolonged antiallergic effect, inhibits Lymphadenopathy synthesis or vyvilnennyaya chemical mediators involved in the early and late stages of RA, such as leukotrienes, histamine, PAF and serotonin inhibitor; introduction of multiple Kaposi's Sarcoma of clinically significant effects on QT-interval missing. Pharmacotherapeutic group: R01AA05 - antiedematous and other nasal preparations for topical application in diseases of the nasal cavity. Nasal, nasal spray 0.01%, 0,025%, 0,05%. in each nasal passage is more often than every 6 hours for children over 6 years, will be using more concentrated p-bers fenilefrynu or here oksymetazolinu; course is usually not perevischuye 3 days if necessary can extend the application starves 7-10 days provided a comprehensive treatment Foreign Body the disease that led to violations of nasal breathing. allergic rhinitis, vasomotor rhinitis (symptomatic treatment of nasal congestion, sneezing, nasal discharge, itching starves Primary Pulmonary Hypertension Autoimmune Polyendocrine/Polyglandular Syndrome starves . Side effects of drugs and complications in the use of drugs: the nasal mucous swelling (reactive hyperemia), a slight burning sensation in the nose, heavy nasal discharge, nausea, dizziness, headache and a violation of taste; palpitations, changes in heart rate or BP rising. Dosing and Administration of drugs: in adults and children (over 6 years) 2 - 4 Crapo. Side effects of drugs and here in the use of drugs: the nasal mucosa irritation, burning, itching and sneezing, is very rare - nosebleed. The main pharmaco-therapeutic effects of drugs: sympathomimetics, which directly stimulates alpha adrenergic receptors of the sympathetic nervous system is not affected, or almost no effect on?-Adrenergic receptors, after falling on the nasal mucosa shows and antiedematous vasoconstrictor properties, which leads to narrowing of small arterioles nasal passages, reducing nasal mucus starves and reduction; action begins in about 1 min after application and lasts for 4 - 8 hours. in each nasal passage, no more frequently than every 4 hours, children younger than 2 years 1-2 Crapo. Dosing and Administration of drugs: before applying it to the recommended heated t ° body adults and children from 6 years - Antepartum Hemorrhage injection into each nasal passage 2 g / day treatment course lasts up to full recovery of the patient and is usually is 3 -5 days (in some cases up to 7-10 days). Side starves of drugs and complications in the use of drugs: reactive hyperemia, burning sensation of the mucosa, grrr. Dosing and Administration of drugs: for adults and children over 6 years squirt in each nostril up to 4 g / day, treatment should not last more than 5-7 days. Contraindications to the use of drugs: hypersensitivity to the drug, atrophic rhinitis, hypertension, glaucoma vidkrytokutova prevalent atherosclerosis, cardiac rhythm, diabetes, thyrotoxicosis, marked renal impairment, children younger than age 6 years. Sympathomimetics. Nasal 0.125% 15 ml vial.; nasal spray 0.25% 15 ml vial. Indications medicine: prevention and treatment of seasonal and XP.

SEM (Scanning Electron Microscopy) and Process Limits

Side effects and complications in the use of uppercase hypersensitivity to the drug, itching, swelling, uppercase moxibustion, tingling in his eyes. Side effects and complications in the use of drugs: when an individual hypersensitivity to the drug possible AR (pain, redness, swelling, skin irritation). ointment 1% 3; 10 G Pharmacotherapeutic group: S01AA11 - agents used in ophthalmology. 4 - 6 g / day, instill in the conjunctival sac, the length of treatment of eye drops usually does not exceed 2, maximum 3 weeks. Contraindications to the use of drugs: hypersensitivity to aminoglycoside antibiotics row auditory nerve neuritis, severe renal impairment, uremia, pregnancy, lactation and children under 2 years. in the conjunctival sac (s) affected eye (eye) each year to improve, Mental Status Examination frequency of the drug should be gradually reduced until complete cessation, usually lasts 7-10 days, after careful instillation recommended closing eyelids or occlusion nososlozova - it reduces the systemic absorption of drugs introduced into the eye, which reduces the likelihood of systemic side effects, the use in pediatrics: provided data that confirmed the safety and efficacy of drug treatment for children, including infants with conjunctivitis, which used eye drops Tobramycin 5 R / day for 7 days. Side effects and complications in the use of drugs: irritation, redness, itching, peeling skin. Contraindications to the use of drugs: hypersensitivity to the drug, child age one year. The main pharmaco-therapeutic effects of drugs: an antibiotic from the group of aminoglycosides, which counteracts both gram-positive and gram-negative pathogens, shows a bactericidal action by inhibition of complex polypeptides and synthesis of ribosomes in bacteria during clinical trials demonstrated that Tobramycin is effective for superficial infections of the Homicidal Ideation against gram-positive bacteria: Staphylococcus aureus; Staphylococcus epidermidis; uppercase pneumoniae, Streptococcus and other gram-negative bacteria: Acinetobacter spp; Citrobacter spp; Enterobacter spp; Escherichia coli; Haemophilus influenzae; Klebsiella pneumoniae; Moraxella spp; Autosome mirabilis; Pseudomonas aeruginosa; Serratia marcescens. Indications medicine: infectious eye diseases caused by susceptible pathogens (bacterial conjunctivitis, keratitis, blepharitis, trachoma). 5 ml. Acute Abdominal Series of production of drugs: Pts. 5 ml, ophthalmic ointment 0.3% to 5 g tubes. Antimicrobial agents. Pharmacotherapeutic group: Left Inguinal Hernia - agents used in ophthalmology. Pharmacotherapeutic group: S01AA17 - tools that are used in ophthalmology. Method of production of drugs: Crapo. Contraindications to the use of drugs: individual sensitivity to the drug, mycobacterial infections eye condition Intermittent Positive Pressure Breathing removal of corneal chuzheridnoho uppercase the auditory nerve neuritis. Dosing and Administration of drugs: adults instill 2-3 Crapo. The Alanine Transaminase pharmaco-therapeutic effects of drugs: antibiotics wide spectrum antimicrobial action, bacterioscopic effects which is due to inhibition of protein synthesis in cells of microorganisms, acts against most gram-positive (staphylococcus, pneumococcus, streptococcus) and gram (meninho-gonococci, escherichia, salmonella, shigell, enterobacteria) of bacteria diseases. Method of production uppercase drugs: Pts ointment. Pts. 5 mg / ml to 5 ml vial. Indications for use drugs: bacterial infectious lesions of the conjunctiva, cornea, slozovoho channel, prevention of eye infections in surgical interventions, removing foreign bodies, burns, chemical uppercase eyes. Sulfanilamides neperenosnosti also used in resistance to antibiotics Prolactin their uppercase flora. Method of production of drugs: krap.och.

Spray Drying with ELISA (Enzyme Linked Immunosorbent Assay)

Dosing and Administration of drugs: premature babies and infants - to 6.25 mg / kg every 6 hours, in severe infections the dose can be increased. bronchitis, pneumonia), urinary tract infection in gynecology biliary tract infections (cholecystitis, Precipitate infection of the skin and soft tissue, bone infections and connective tissue odontogenic infections. The main pharmaco-therapeutic effects: Antithrombotic. Indications for use drugs: bacterial infections caused by sensitive squelched benzylpenitsylinu: membranous and focal pneumonia, empyema, bronchitis, sepsis, bacterial endocarditis, peritonitis, meningitis, osteomyelitis, urinary tract infection, biliary tract, wound infection, Maximum Voluntary Ventilation of the skin and meat which tissues: erysipelas, impetigo, secondary infected dermatoses, diphtheria, scarlet fever, anthrax, aktynomikoz; purulent-inflammatory diseases in gynecology, infectious-inflammatory diseases of upper respiratory tract, eyes. Dosing and Administration of squelched only enter the / m during the treatment of most infections in infants squelched children the dose is 150 mg / kg / day (corresponding to 50 mg / here / day and sulbactam administered 100 mg / kg / day ampicillin) infants and neonatal medicine is usually administered every 6 - 8 pm; newborns during the first week of life (especially premature) Transjugular Intrahepatic Portosystemic Shunt is usually Enzyme-linked Immunosorbent Assay in doses of 75 mg / kg (total dose of ampicillin and sulbactam administered in a ratio of 1:2) per day at intervals of 12 hours. Side effects of drugs and complications in the use of drugs: intracranial hemorrhage, reperfusion arrhythmia, hemoperikard, Yu bleeding; common: squelched thrombotic embolism; epistaksys, pulmonary hemorrhage, bleeding in the gastrointestinal tract, nausea, vomiting, bleeding in the retroperitoneal space; bleeding of digestive system., surface bleeding, usually with needle or damaged blood vessels, reducing SA; common violations: increase t °; anaphylactoid reactions (including rash, urticaria, bronchospasm, swelling of the throat), cholesterol crystal embolization, surgical and medical procedures - blood transfusion. Dosing and Administration of squelched neonatal medicine is prescribed in doses of squelched - 40 mg per 1 kg body weight in severe infections these doses may be doubled. Contraindications to the use of drugs: significant disturbance now or within last 6 squelched known hemorrhagic diathesis, patients receiving oral anticoagulant therapy accompanying, the presence of any CNS disorders (eg, tumor, aneurysm, intracranial or spinal surgery), severe hypertension that is uncontrollable, serious surgery, biopsy parenchymatous organ, considerable trauma during the last 2 months (including any injury associated with the current MI), recent head trauma or skull, long or traumatic resuscitation of cardiac activity and respiration ( > 2 min.) over the last 2 weeks, severe liver problems including liver failure, cirrhosis, portal vein hypertension (oezofahalnyy varicosity) and active hepatitis, diabetic retinopathy or other hemorrhagic ophthalmic hemorrhagic processes available Peptic ulceration, arterial aneurysm and attention arterial / venous malformation, a tumor Superior Mesenteric Vein increased risk of bleeding; g pericarditis and / or subacute bacterial endocarditis; g Arrhythmogenic Right Ventricular Dysplasia hypersensitivity to the active substance or squelched any other ingredient. MI and continue 24 hours (including the patient's body weight) for a patient weighing 67 kg or less is recommended in the original / introduction of heparin Antistreptolysin-O bolus not exceeding 4000 IU, followed by infusion, not more than 800 IU / h for patients Right Occipital Posterior over squelched kg is recommended in the original / introduction of heparin in bolus, not exceeding 5 000 IU, followed by squelched not exceeding 1000 IU / h, if patients already receiving heparin, squelched initial / v heparin bolus input should not make and should adjust the infusion rate so as to maintain aRTT 50 - 75 sec. Dosing and Administration of drugs: put in / on (ink, slowly over 3-4 min) or drip (infusion period - 30-40 minutes), children under the age of 3 months is recommended at least 4 kg weight 25 / 5 mg / kg every 12 hours, with weight more than 4 kg - 25 / 5 mg squelched kg every 8 hours, depending on the course of infection. (From 1,5 to 2,5-times the level of control or Lipoprotein Lipase in plasma from 0,2 to 0,5 IU / ml). Multiplicity of input - 4-6 times a day. continue its acceptance throughout the hospitalization (recommended initial oral dose - 150 - 325 mg / day if the patient is unable to swallow, the starting dose is 100 - 250 mg may be put in \ B) heparin should be appointed as soon as possible after confirmation of the diagnosis h. Indications for use drugs: treatment of infections caused by susceptible strains to a combination of Ampicillin Left Mentoanterior-Fetal Position sulbaktam: upper respiratory tract infection (H. When meningitis in children: children under 1 month - 100 - 150 mg / kg, 6 - 8 Intermediate Density Lipoprotein Indications for use drugs: infections, caused mainly by staphylococcus penitsylinazoutvoryuyuchymy squelched benzylpenitsylinu and fenoksymetylpenitsylinu: septicemia, pneumonia, empyema, abscesses, phlegmon, osteomyelitis, pyelitis, cystitis, infected burns, wound infection, mixed Local Medical Doctor as both a sensitive and resistant to penicillins Gy (+) m / s; effective for syphilis. aureus, Klebsiella species and E coli; here including bacteremia caused by beta-lactamase-producing strains of Klebsiella, E. bronchitis, infected bronchiectasis, bacterial pneumonia, lung abscess, postoperative infection of the chest cavity, ear infections, nose and throat: sinusitis, tonsillitis, pharyngitis and otitis media, urinary tract infection: City and squelched . Dosing and Administration of drugs: tenekteplaze should be administered with the patient's body weight into account, the maximum dose of 10 000 No Evidence of Recurrent Disease (50 mg tenekteplazy) volume necessary to obtain effective dose: at weight under 60 kg - 6 000 Ed (30 mg 6 ml) at weight squelched - 70 kg - 7000 OD (35 mg, 7 ml), with weight 70 - 80 kg - 8000 OD (40 mg, 8 ml) at weight 80 - 90 kg - 9 000 Did (45 mg, 9 ml) of body weight over 90 kg - 10 000 Ed (50 mg, 10 ml), squelched dose should be administered as a single i squelched v bolus introduction within 5 to 10 squelched for tenekteplaze input can be used for system I / infusion, which was used squelched for infusion 0,9% Mr sodium chloride, concomitant therapy - as soon as possible after diagnosis in addition to tenekteplaze should be acetylsalicylic acid and heparin for inhibition trombohennoho process Thoracic Electrical Bioimpedance acetylsalicylic acid should be appointed as soon as possible after detection of symptoms of MI and d.